News Feature | Published:

Can cancer clinical trials be fixed?

Nature Biotechnology volume 29, pages 1315 (2011) | Download Citation

  • An Erratum to this article was published on 06 May 2011

This article has been updated

As oncology drug after oncology drug fails to achieve accelerated approval, sponsors are seeking other ways to speed trials. Malorye Allison investigates.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Change history

  • 09 February 2011

    In the version of the article originally published, it was stated that “Avastin was studied in combination with Taxol in all these trials, and compared to Taxol alone.” It should have read. “Avastin was studied in combination with chemotherapy.”In addition, it stated that the FDA had rescinded approval of Avastin for metastatic breast cancer. It should have read, the FDA “recommended removal of the breast cancer indication from the Avastin label…” The errors have been corrected in the HMTL and PDF versions of the article.

References

  1. 1.

    Nat. Biotechnol. 28, 879–880 (2010).

  2. 2.

    The Pink Sheet Daily, Elsevier Business Intelligence, 27 August 2010.

  3. 3.

    et al. J. Clin. Oncol. 27 Supplement, 1017 (2009).

  4. 4.

    Medscape Today, <> 4 June 2009.

  5. 5.

    et al. Nature 467, 596–599 (2010).

  6. 6.

    The New York Times, p. 1, 18 September 2010.

  7. 7.

    et al. Nature 448, 561–566 (2007).

  8. 8.

    Anonymous. Innovation or Stagnation: Challenge and Opportunity on the Critical Path to New Medical Products (FDA, March 2004). <>

  9. 9.

    Anonymous. Qualification Process for Drug Development Tools. Draft Guidance (US Department of Health and Human Services, FDA, CDER, October 2010). <>

  10. 10.

    Nat. Biotechnol. 28, 383–384 (2010).

  11. 11.

    et al. J. Clin. Oncol. 27, 4398–4405 (2009).

  12. 12.

    & J. Clin. Oncol. 28, e226 (2010).

Download references

Author information

Affiliations

  1. Acton, Massachusetts

    • Malorye Allison

Authors

  1. Search for Malorye Allison in:

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nbt.1746

Further reading

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing